Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Stability During Anesthesia Induction with Remifentanil
NCT03861377Phase 4Completed
- Sponsor
- Helse Fonna
- Start
- Jun 2020
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remifentanil (3 arms), sponsored by Helse Fonna. Primary endpoints: Systolic Blood Pressure at 7.5 minutes and Heart Rate at 7.5 minutes. Started Jun 2020; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT03861377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03861377.